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Abstract
Background: In Ghana, pre-school-aged children (PSAC) are at risk of intestinal schistosomiasis and are living in
need of praziquantel treatment. To better assess the infection burden within this vulnerable demographic group,
we have provided a comparative assessment of the prevalence of Schistosoma mansoni in pre-school-aged children
by urine circulating cathodic antigen (CCA) dipsticks, real-time PCR Taqman® faecal assays and Kato-Katz
coproscopy.
Methods: In all, 190 pre-school-aged children were sampled from three endemic communities (viz. Tomefa,
Torgahkope/Adakope, and Manheam) around Weija dam, Southern Ghana. Fresh stool and urine samples were
collected from all participants for diagnosis.
Results: Among all the three communities, the urine-CCA assay recorded the highest prevalence values of 90.5%
(95% CI 80.4–96.4), 87.9% (95% CI 76.7–95), and 81.2% (95% CI 69.9–89.6) in Tomefa, Torgahkope/Adakope, and
Manheam respectively. Prevalence by real-time PCR was 50% (95% CI 35.5–64.5), 8% (95% CI 2.2–19.2) and 16.7%
(95% CI 8.3–28.5), while by Kato-Katz was 55.6% (95% CI 42.5–68.1), 8.6% (95% CI 2.9–19) and 11.6% (95% CI 5.1–
21.6) respectively. Children aged 1 year and over were found to be positive with the urine-CCA assay; by the ages
of 3–4, over 50% were urine-CCA patent. The sensitivity and specificity of the POC-CCA dipsticks, when compared
against the combined results of Kato-Katz/TaqMan results was found to be 84.1% (95% CI = 72.7–92.1) and 12.9%
(95% CI = 6.6–22) respectively.
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Conclusions: We propose that the urine-CCA dipstick may be a useful rapid diagnostic tool to estimate the
prevalence of intestinal schistosomiasis in PSAC, particularly in rapid identification of at-risk areas. However, our
assessment has shown that it possible to record false positives when compared to combined Kato-Katz and qPCR
results. To guide PSAC praziquantel treatment needs, we propose the urine CCA assay should be included in
routine surveillance of intestinal schistosomiasis alongside other diagnostics such as Kato-Katz and urine filtration.
Keywords: Schistosomiasis, Circulating cathodic antigen, Kato-Katz, Schistosoma mansoni, Diagnostic, Real-time PCR
Taqman®
Background
Schistosomiasis is a water-borne parasitic disease that is
caused by chronic infection with flukes of the genus
Schistosoma. The disease has serious public health impli-
cations, affecting 230 million people living in 54 coun-
tries [1, 2], with an estimated cost of eight million
disability-adjusted life years [3].
In sub-Saharan Africa, Schistosoma mansoni is the
predominant cause of intestinal schistosomiasis. The
most commonly used method for diagnosing S. mansoni
infection is by coproscopy with the Kato-Katz thick fae-
cal smear which detects eggs shed in stool samples [4].
This assay has the advantage of being relatively cheap to
perform, and therefore ideal for many resource poor set-
tings where the disease occurs [1]. However, this assay
may have low detection sensitivity in communities with
low prevalence and intensity of infection [5]. With the
expected expanded access to praziquantel [6–8], and a
drive towards the interruption of transmission [8], there
is the need for more sensitive diagnostic tools that can
detect infections at low disease prevalence and intensity
settings, also in currently excluded demographic groups
such as pre-school-aged children (PSAC) in high en-
demic areas.
Another S. mansoni diagnostic assay is the schisto-
some DNA by real-time PCR Taqman® assay [9, 10]. Al-
though this assay is based on eggs that have been shed
into stool samples, the detection of DNA potentially
gives this assay greater diagnostic sensitivity than the
Kato-Katz assay [11–13]. Therefore, this assay can be
used for disease surveillance in communities that are ap-
proaching interruption of transmission. This assay, how-
ever, has the limitation of being expensive and requiring
highly skilled molecular biology technicians and equip-
ment to operate. In addition, this assay is limited by day-
to-day variations in Schistosoma egg production [14],
and the low volume of faecal sample that is processed
for DNA extraction.
Both adult male and female Schistosoma worms se-
crete Circulating Cathodic Antigen (CCA) in their vom-
itus [15, 16], therefore the detection of the CCA antigen,
either in serum or urine, in an individual gives an
indication of the presence of active infection(s) in a hu-
man host. The commercially available urine (point-of-
care) POC-CCA diagnostic assay is in a lateral flow
format (ICT International, Cape Town, South Africa)
making it very user friendly. A major advantage of the
urine CCA kit is the significantly minimal variation in
the day-to-day production of this antigen by the adult
worm, compared to variations in egg production and re-
lease by the adult female worm [17]. It may therefore be
expected that urine-CCA assay will be more sensitive
than the egg- based Kato-Katz [5, 11, 18–20] and real-
time PCR Taqman® assays [11]. The urine CCA assay
also has the advantage of detecting S. mansoni infections
in urine, and not stool samples, which can be challen-
ging to obtain from some cohorts within endemic com-
munities such as PSAC. The urine-CCA assay, however,
has the limitation of not being able to reliably detect S.
haematobium infections, and may therefore be of limited
use in areas of mixed infection.
Intestinal schistosomiasis infection has been detected
in PSAC (viz. aged between 1 and 5 years) in Uganda
[21, 22] and some other African countries [22]. From
the current literature, there is no contemporary report
on the prevalence of intestinal schistosomiasis among
PSAC in Ghana - only Bosompem and colleagues [23],
have reported on the prevalence of urinary schistosomia-
sis within this cohort in a endemic community in Ghana.
Despite the recommendation [22] to include PSAC in
routine praziquantel treatment activities, in Ghana the
focus is still on school children, leaving out the at-risk
PSAC cohort. In order to improve the chances of the in-
clusion of PSAC in the national control treatment strat-
egies, there is the need for highly sensitive diagnostic
assays to better assess disease burden within this cohort.
With the absence of a gold standard for the detection
of S. mansoni infections [14], it is important for control
programs or disease control interventions to be flexible,
and apply the best diagnostic kit for a particular setting.
In Ghana, routine field surveillance activities mainly
utilize the Kato-Katz assay - a situation that can lead to
an under estimation of disease prevalence and intensity,
given the low diagnostic sensitivity of this assay under
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some disease settings. This could have negative impacts
on the many years of control activities against the dis-
ease. In this work, we have applied the (point-of-care)
POC-CCA diagnostic assay to detect S. mansoni infec-
tions in the urine of PSAC in Ghana. We evaluated this
assay by comparing the CCA prevalence values with




The Institutional Review Board (IRB) of the Council for
Scientific and Industrial Research (research protocol
number 003/CSIR-IRB/2016) and the Liverpool School
of Tropical Medicine (research protocol number 16–
044) granted ethical clearance for this study. This study
is embedded with a larger study on the expanded access
to praziquantel and albendazole in whole communities,
see Campbell et al. (2018) and Cunningham et al. (in
submission) for full details of sensitisation, enrolment
and sampling procedures. Briefly, all participants were
enrolled after community, household and individual sen-
sitisation. Prior to sample collection, all parents or
guardians signed a written consent form, and all partici-
pating PSAC assented. During the informed consent
process, the importance of diagnosis in the determin-
ation of praziquantel treatment needs was explained to
all parents and guardians. After sample collection, prazi-
quantel was mass-administered in all communities to
cover both study participants and non-participants using
the World Health Organization recommended doze
pole. There was also special care taken to ensure that all
infected PSACs were treated.
Study area
In the selection of study areas, reference was made to
the National NTDs Control survey data that used the
Kato-Katz assay to detect schistosomiasis infections. An
initial set of twenty potential study areas were selected,
and screened to arrive at a final set of three sites, which
had schistosomiasis prevalence of at least 10%, based on
school surveys performed by the Biomedical and Public
Health Research Unit of CSIR. Additional selection cri-
teria for the study sites included all-year-round accessi-
bility by road and a low migration rate. All three sites
were located around the Weija dam in Southern Ghana
(Fig. 1). The sampled communities were Tomefa (longi-
tude: − 0.37688, latitude: 5.57309), Torgahkope / Ada-
kope (longitude: − 0.38176, latitude: 5.6055) and
Manheam (longitude: − 0.39127, latitude: 5.55229). The
Fig. 1 Studies sites, located in the Greater Accra region of Ghana, around the Weija dam
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Weija dam is the main reservoir from which water is
sourced and treated for supply to more than half of the
2 million population of Accra, the capital city of Ghana.
There are two distinct weather patterns within the en-
demic communities (viz. dry and rainy season). Because
of the importance of the Weija reservoir, it never dries
up during the dry season, so there is all-year-round
availability of water in the dam, which could also be
translated to the possibility of all-year-round transmis-
sion of schistosomiasis. For all the three sampled com-
munities, fishing was the main of source of economic
livelihood. Generally, the men did the fishing, whilst the
women were involved in fish mongering. These fishing
activities resulted in many water contact opportunities,
which could be infective.
Sample size calculation
This study is part of a larger intervention study by the
COUNTDOWN Consortium [6]. Sample size calculation
for this study was performed as described previously (6),
using the formula below:
n ¼ Nz2ρq= E2 N−1ð Þ þ z2ρq 
where: N = population size (approx. 1500 people); z =
1.96 (confidence level 95%); p = estimated prevalence
(20%); q = 1-p; E = accuracy of estimation (0.03).
A final sample size of 658 people (including adults,
school-age children, and PSAC) was computed for each
community considering variations in age and sex.
Sample collection
Children from ages 1 to 5 years were classified as PSAC.
This study used samples provided by PSACs from whole
community sample collection that was carried out in the
second quarter of 2017 as part of a larger COUNT-
DOWN Consortium study [6] in the three study sites
(Fig. 1). In all, 190 PSAC from the three sampling areas
participated in this study. All study participants were
registered and given a unique identification code, which
were then used to label empty urine and stool containers
for sample collection. During the informed consent
process, it was requested that participants present the
first urination and bowel movement of the day as sam-
ples for parasitological analyses. Each of the 190 PSACs
provided single urine and stool samples.
Laboratory procedures
Duplicate Kato-Katz thick smear slides were prepared
for each stool sample (Sterlitech) as done elsewhere [11,
24]. Stool samples were assessed (using Olympus model
CH and Boshida BD-SW30 microscopes) at × 400 mag-
nification by two different experienced technicians. As a
quality control check, the lead technician examined 10%
of the Kato-Katz slides in order to confirm positive or
negative results. All urine samples were tested for S.
mansoni using the CCA test kits (ICT International,
Cape Town, South Africa) following the manufacturer’s
protocol. In brief, all POC-CCA test reagents were equil-
ibrated to room temperature prior to use. A straw drop-
per was used to transfer two drops (each drop is
equivalent to 40 uL) of urine from the urine sampling
container to the circular receptacle on the POC-CCA
cassette. After 20 minuntes, the POC-CCA test were
scored as follows, negative (−), light/trace band (+),
medium band (++) and heavy band (+++). The visual as-
sessment was carried out independently by two trained
technicians using a visual guide to help inform their as-
sessment (Additional file 1). In addition, the samples
were tested for S. mansoni infection using a real-time
PCR Taqman® assay. In brief, DNA was isolated from
each stool sample using the QIAamp DNA mini kit
(QIAGEN, Hilden, Germany) following the manufac-
turer’s protocol. The phocin herpes virus 1 (PhHV-1)
was used as an internal control for all DNA extractions
[10, 25]. For the real-time PCR Taqman® assay, the
internal-transcribed-spacer-2 sequence of the S. mansoni
ribosomal RNA gene (GeneBank Accession Number:
AF503487) was targeted [10] as done elsewhere for real-
time PCR diagnosis of schistosome parasite infections
[10, 25]. Each PCR reaction mix (20 μL total volume),
contained 200 nM of primers (SP: 5′-GGT CTA GAT
GAC TTG ATY GAG ATG CT-3′; ASP 5′-TCC CGA
GCG YGT ATA ATG TCA TTA - 3′), 2 μL of DNA,
100 nM of Taqman probe (5′-TGG GTT GTG CTC
GAG TCG TGG C – 3′), and 12.5 μL of iQ™ Supermix
(Bio-Rad Laboratories Inc., California, USA). Each run
was performed on the Rotor Gene thermocycler (QIA-
GEN, Hilden, Germany) using the following reaction
conditions: initial incubation at 95 °C for 3mins, followed
by 50 cycles of 95 °C for 15 s, 60 °C for 30s, 72 °C for 30s,
and a final incubation step of 72 °C for 2mins. All qPCR
runs were performed on 96-well plates, which also had a
positive control of S. mansoni DNA extracted from the
Liverpool of Tropical Medicine collection of whole adult
worms. A sample was scored as positive if the internal
control amplified, and the S. mansoni specific primers
resulted in amplification which had the same melt peak
profile as the S. mansoni positive control. All qPCR runs
were accompanied by negative controls of sterile double
distilled water. After all qPCR runs, 31 of the DNA sam-
ples did not show amplification of the internal PhHV-1
control, and were thus excluded from the study leaving a
total of 160 samples for analyses.
Data management and statistical analysis
Results of the parasitological assessments were recorded
on proforma data sheets. The data were then double
Armoo et al. BMC Infectious Diseases          (2020) 20:301 Page 4 of 10
entered in Microsoft Excel prior to statistical analyses.
The R programming software, version 3.2.2 [26] was
used to generate summary tables and figures. The same
software was used to determine the 95% confidence in-
tervals for prevalences employing the exact method, and
also perform Fisher’s exact test to determine differences
between prevalences in relation to diagnostic techniques
and communities of origin. The Kappa statistic was used
to give a quantitative agreement between the CCA re-
sults and the composite gold standard (Kato-Katz and
qPCR). Interpretation of Kappa values, are as follows: <
0 less than chance, 0.01–0.20 slight agreement, 0.21–
0.40 fair agreement, 0.41–0.60 moderate agreement,
0.61–0.80 substantial agreement and 0.81–0.99 almost
perfect agreement [27].
Results
The numbers of PSAC from the three communities who
participated in this study differed between tests and site,
due to the availability of samples. The following are the
numbers of samples processed per diagnostic assay from
each community: Tomefa 63 samples were screened
using both Kato-Katz and POC-CCA, 50 were screened
using TaqMan qPCR. From Torgahkope/ Adakope 69
samples were processed with both Kato-Katz and POC-
CCA, 60 were screened with TaqMan qPCR. A total of
58 samples from Manheam were screened using Kato-
Katz and POC-CCA, 50 of these samples were also
screened with the TaqMan qPCR.
Evaluation of the prevalence of S. mansoni determined by
the urine CCA, real-time PCR Taqman® and Kato-Katz
assays
For the purpose of evaluation, the prevalences of S.
mansoni infection in the PSAC, as determined by the
urine CCA, real-time PCR Taqman®, and Kato-Katz as-
says, are presented in Fig. 2 and Table 1. The results of
the POC-CCA were evaluated to both include and ex-
clude light/trace bands. In both instances the POC-CCA
identified the largest number of positives from all com-
munities with Tomefa identified as having the highest
prevalence at 90.5% (57/63; 95% CI = 80.4–96.4) when
light/trace bands are counted and 57.1% (36/63; 95%
CI = 44.0–69.5) without the light/trace results. The
POC-CCA, when including light/trace results, identified
Torgahkope/Adakope as having the second highest
prevalence, 87.9% (51/58; 95% CI = 76.7–95), however
when the light/trace results were excluded Manheam
was identified as having the second highest prevalence,
27.6% (16/58; 95% CI = 16.7–40.9). Manheam was identi-
fied as having the lowest prevalence of S. mansoni when
the light/trace results were included, 81.2% (56/69; 95%
CI = 69.9–89.6) and Torgahkope/Adakope when these
were excluded, 11.6% (8/69; 95% CI = 6.3–25.8). The re-
sults of both the Kato-Katz and real-time PCR reflected
Fig. 2 Positive rates across the three sampling sites for Kato-Katz, qPCR and CCA results, *with and **without faint/trace bands
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the results of the POC-CCA, when the light/trace results
were excluded. Once more Tomefa was identified as
having the highest prevalence out of three communities
by Kato-Katz, 55.6% (35/63; 95% CI = 42.5–68.1) and
qPCR, 50% (25/50; 95% CI = 35.5–64.5), followed by
Manheam; Kato-Katz 11.6% (8/69; 95% CI = 5.1–21.6),
Taqman PCR 16.7% (10/60; 95% CI = 8.3–28.5). Torgah-
kope/Adakope was identified as having the lowest preva-
lence by Kato-Katz, 8.6% (5/58; 95% CI = 2.9–19) and
real-time PCR, 8% (4/50; 95% CI = 2.2–19.2).
In all three sites, the POC-CCA (with trace results)
gave the highest prevalence of intestinal schistosomiasis
infection (Fig. 2). This was followed by POC-CCA preva-
lences without trace results, although the confidence in-
tervals overlap with those of the Kato-Katz and real-time
PCR. Indicating that without trace results the POC-CCA
results can be similar to results from Kato-Katz and
real-time PCR.
The geometric mean of S. mansoni egg per gram (epg)
of stool samples per community that were determined
by the Kato-Katz assay is presented in Fig. 3. Tomefa re-
corded the highest geometric mean epg of 239.78, which
was significantly different from the 87.99 of Torgahkope
/ Adakope (P = 2.2 × 10− 16), and the 96.36 of Manheam
(P = 5.1 × 10− 15). There was however, no statistically sig-
nificant difference between the geometric epg of Torgah-
kope / Adakope and Manheam (P = 0.538).
Sensitivity, specificity and kappa score of urine CCA assay
against a composite gold standard of real-time PCR and
Kato-Katz assay positives
In the absence of a robust gold standard for the detec-
tion of S. mansoni infections [14], the sensitivity and
specificity of the urine CCA assay was determined using
the combination of positive results from the real-time
PCR Taqman® and Kato-Katz assays as a composite gold
standard as recommended elsewhere [28, 29]. This ap-
proach was adopted due to the consistently high preva-
lence values of the CCA compared to the PCR Taqman®
and Kato-Katz assays. When faint/trace bands were in-
cluded, the urine CCA assay had a sensitivity of 84.1%
(95% CI = 72.7–92.1) and, 36.5% (95% CI = 24.7–49.6)
when faint/trace bands were excluded. The specificity
for the CCA test was 12.9% (95% CI = 6.6–22) and 76.5%
(95% CI = 66–85) when faint/trace bands were included
and excluded, respectively (Table 2). The Kappa values
for the CCA showed less than chance agreement (− 0.03)
with the composite gold standard when faint/trace bands
Table 1 Prevalence of the S. mansoni infections determined by the three diagnostic assays across all study areas. For all test assays;
n represents the total number of participants; Pos = number positive; and Prev (95% CI) = prevalence with 95% confidence interval
Study area Diagnostic assay
Kato-Katz PCR POC-CCAa POC-CCAb
n Pos Prev (95% CI) n Pos Prev (95% CI) n Pos Prev (95% CI) n Pos Prev (95% CI)
Tomefa 63 35 55.6 (42.5–68.1) 50 25 50 (35.5–64.5) 63 57 90.5 (80.4–96.4) 63 36 57.1 (44–69.5)
Torgahkope-Adakope 58 5 8.6 (2.9–19) 50 4 8 (2.2–19.2) 58 51 87.9 (76.7–95) 69 8 11.6 (5.1–21.6)
Manheam 69 8 11.6 (5.1–21.6) 60 10 16.7 (8.3–28.5) 69 56 81.2 (69.9–89.6) 58 16 27.6 (16.7–40.9)
Total 190 48 25.3 (19.3–32.1) 160 39 24.4 (17.9–31.8) 190 164 86.3 (80.6–90.9) 190 60 31.6 (25–38.7)
aWith light/trace results
bWithout light/trace results
Fig. 3 Geometric mean of S. mansoni epg numbers across the three study sites
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are included and a slight agreement (0.14) when faint/
trace bands are excluded (Table 2).
Age and positive status
The prevalences of S. mansoni infections among PSAC
(with age stratification), as determined by the three diag-
nostic assays, are presented in Table 3. In all the study
communities, the urine CCA assay produced the highest
number of positives in PSAC 0–1 years of age. The real-
time PCR Taqman® was also able to detect infection in
this group in Manheam (Table 3). The urine CCA assay
also gave the highest prevalence in all the communities
(Table 3). It is also clear that in the latter ages (4–5
years) of the PSAC, all three assays were able to detect
infections in all the communities. Our findings show
early exposure to infection in these endemic areas, and
the need for education and behaviour change, since
PSAC do not have to perform mandatory economic and
lifestyle activities that will expose them to infection from
the dam. A common source of infection among the
PSAC will be through water carried in pans from the
dams for their bathing. With appropriate education,
water for bathing can be stored and used after 3 days,
when the cercariae are less likely to be infective [1]. Our
findings also reveal PSAC treatment needs, and the need
for an infant formula for praziquantel.
Discussion
In this study, we evaluated the urine CCA assay against
the real-time PCR Taqman® and Kato-Katz assays for
the detection of S. mansoni in three endemic communi-
ties in southern Ghana. PSAC are an important cohort
within endemic communities [30] because they carry
low parasite densities due to their relatively short period
of exposure to infection. This requires that very sensitive
diagnostic assays must be applied to limit the risk of
under-estimating disease prevalence within this cohort.
It is the first occasion that intestinal schistosomiasis has
been observed to be common in Ghanaian PSAC.
In all the three study communities, the urine CCA
assay recorded the highest prevalence values among the
three assays (Fig. 2). A review of multiple studies by Kit-
tur and colleagues [5] revealed that when the Kato-katz
prevalence is less than 20%, the urine CCA prevalence is
3 to 6 fold higher. In addition, a recent study found that
urine CCA prevalence could be up to 8 fold higher than
Kato-katz prevalence in low endemicity settings [31].
We observed a similar trend in Manheam, which had a
Kato-Katz prevalence of 7% (Fig. 2); and Torgahkope/
Adakope, which had a Kato-Katz prevalence of 21% (Fig.
2). Our findings confirm reports that the urine CCA
assay is capable of identifying more samples as positive
Table 2 Sensitivity, specificity and Kappa scores of the POC-CCA
test versus combined Kato-Katz and PCR results
Kato-Katz + PCR Sensitivity Specificity Kappa
ScorePos Neg (95% CI) (95% CI)
CCAa Pos 53 74 84.1 (72.7–92.1) 12.9 (6.6–22) −0.03
Neg 10 11




Table 3 Positives stratified by age for Kato-Katz, qPCR and CCA, for each community: Tomefa, Torgahkope/Adakope and Manheam.
For all test assays; n represents the total number of participants; Pos = number positive; and (Prev; 95% CI) = prevalence with 95%
confidence interval
Age Kato-Katz PCR CCAa CCAb
n Pos (Prev; 95% CI) n Pos (Prev; 95% CI) n Pos (Prev; 95% CI) n Pos (Prev; 95% CI)
Tomefa
0–1 2 0 2 0 3 3 (100; 29.9–100) 3 2 (66.7; 9.4–99.2)
2–3 42 24 (57.1; 41–72.3) 35 13 (37.1; 21.5–55.1) 42 37 (88.1; 74.4–96) 42 24 (57.1; 41–72.3)
4–5 13 9 (69.2; 38.6–90.9) 11 6 (54.5; 23.4–83.3) 13 12 (92.3; 64–99.8) 13 7 (53.8; 25.1–80.8)
Torgahkope/Adakope
0–1 1 0 1 0 1 1 (100; 2.5–100) 1 0
2–3 37 6 (16.2; 6.2–32) 28 5 (17.9; 6.1–36.9) 37 32 (86.5; 71.2–95.5) 37 6 (16.2; 6.2–32)
4–5 19 2 (10.5; 1.3–33.1) 14 2 (14.3; 1.8–42.8) 19 17 (89.5; 66.9–98.7) 19 2 (10.5; 1.3–33.1)
Manheam
0–1 3 0 3 1 (33.3; 0.8–90.6) 3 3 (100; 29.2–100) 3 2 (66.7; 9.4–99.2)
2–3 34 2 (5.9; 0.7–19.7) 32 3 (9.4; 2–25) 34 28 (82.4; 65.5–93.2) 34 6 (17.6; 6.8–34.5)
4–5 24 2 (8.3; 1–27) 22 4 (18.2; 5.2–40.3) 25 19 (76; 54.9–90.6) 25 7 (28; 12.1–49.4)
aWith light/trace results
bWithout light/trace result
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compared to Kato-Katz assay [5, 11, 19, 31–33]. This
study also confirmed (Fig. 2) that the urine CCA assay
can have a significantly higher diagnostic sensitivity than
the real-time PCR Taqman® assay [11]. However, it also
possible that the faint bands are false positives as similar
findings have been found before in other comparative
diagnostic studies [34]. This feeds into the controversy
around the inclusion or exclusion of faint/trace bands
[35]. Based on our findings and field experience, not all
faint bands are false positives, so cannot be wholly ig-
nored. Other studies have sought to optimise the CCA-
test by developing field friendly urine-concentration
methods [36] or improving the resolution of the scoring
system [37].
A possible explanation for the significantly higher
urine CCA prevalence could be due to the secretion of
the antigen by both sexes of the adult S. mansoni fluke
[15, 16]. This enables the detection of active infections
when only viable adult male flukes live in a host, which
is a likely infection status for PSAC who usually have
low exposure rates to infective agents of schistosomiasis.
In the absence of a reproductively active adult female
fluke, the real-time PCR Taqman® and Kato-Katz assays,
which relies on shed eggs, will diagnose an individual as
negative despite a possible infection with adult male
flukes.
Another possible explanation for the high urine CCA
prevalence is that, unlike the real-time PCR Taqman®
and Kato-Katz assays that may be limited by low infec-
tion density of adult female worms (and a likely low
density of shed eggs), the urine CCA assay is able to de-
tect low densities of the CCA antigen that has been re-
leased by active adult fluke infections. In addition there
is an advantage of significantly lower day-to-day varia-
tions in the secretion of the CCA antigen compared to
variations in egg production by the adult female flukes
[1, 17, 38]. This could make the day and time of sam-
pling an important confounding factor for the findings
of the real-time PCR Taqman® and Kato-Katz assays.
The Kato-Katz prevalence, was 8.6% in Torgahkope/
Adakope and 11.6%, in Manheam (Table 1). For the
Manheam, the real-time PCR Taqman® higher than the
Kato-Katz prevalence (Table 1). A similar trend was re-
ported elsewhere [11], indicating that the real-time PCR
Taqman® can be more sensitive than Kato-Katz assay.
Despite this, the Kato-Katz prevalence was higher than
qPCR in Tomefa. This may be a challenging observation
to explain, but a plausible explanation could be low in-
tensities of egg in stool samples that could not be de-
tected by real-time PCR Taqman® assay because of high
concentration of background DNA from other biological
materials in stool samples. It is also possible that the
population of Schistosoma flukes in Tomefa and Torgah-
kope / Adakope exhibit a high rate of genetic variation
leading to sub-sampling during real-time PCR Taqman®
reaction. Therefore, there may be the need to investigate
genetic differentiation in some field isolates of Schisto-
soma sp., given that extensive genetic variation has been
recorded in some parasite isolates [39].
In the control of schistosomiasis, determining the
minimum age of when infection can be acquired within
an endemic community can be very useful in designing
intervention strategies [21]. However due to the low
numbers of individuals in the different age groups, the
results from an age stratified approach resulted in very
large confidence intervals for the majority of cases
meaning little significant difference could be detected, if
any at all (Table. 3).
Conclusion
In conclusion, the data presented here are consistent
with the findings of previous reports that indicated that
the urine CCA assay is more sensitive than the real-time
PCR Taqman® and Kato-Katz assays [11] but could be
limited by poor specificity, resulting in high numbers of
false positives [34]. This could be tackled by having a
critical view of faint/trace bands. Issues regarding the in-
clusion of faint/trace bands are well understood in the
community and steps have been taken to overcome this
short-fall of the CCA assay by pre-treating the urine and
having a better evaluation protocol for reading the re-
sults. The urine CCA dipstick remains a viable assay for
routine surveillance activities and highlights its use for
routine surveillance of intestinal schistosomiasis in
PSAC in conjunction with MDA campaigns. This CCA
assay can be used alongside commonly used assays such
as the Kato-Katz and urine filtration assays since they
still remain viable. With regards to sample collection
from PSAC, our field experience thought us that it was
more challenging to obtain stool samples from PSAC for
parasitological analyses. Rather, it was significantly less
challenging to obtain urine samples from the PSAC.
This means that with a single urine sample, control
programs can detect both intestinal and urinary schisto-
somiasis status by CCA and urine filtration assays
respectively.
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